ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in ProMIS Neurosciences Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +11 vs. Q2 2022
- Shares held
- 185.0K
- +101.5K (+121.6%) vs. Q2 2022
- Total value
- $1.13M
- +$665.2K (+142.1%) vs. Q2 2022
- New holders
- 13
- 0 more added
- Sold out
- 2
- 0 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northeast Financial Consultants Inc | 100,000 | $613.0K | 0.04% | +100,000 | New |
| Ieq Capital, LLC | 39,191 | $240.0K | 0.01% | +39,191 | New |
| Bank of America Corp | 14,349 | $88.0K | 0.00% | +14,349 | New |
| Claret Asset Management Corp | 12,330 | $75.0K | 0.02% | +12,330 | New |
| JPMorgan Chase & Co | 7,658 | $47.0K | 0.00% | +7,658 | New |
| Morgan Stanley | 5,930 | $36.0K | 0.00% | +5,930 | New |
| UBS Group AG | 2,912 | $18.0K | 0.00% | +2,912 | New |
| Royal Bank of Canada | 1,172 | $7.00K | 0.00% | +1,172 | New |
| Gables Capital Management Inc. | 833 | $5.00K | 0.00% | +833 | New |
| National Bank of Canada | 333 | $2.00K | 0.00% | +333 | New |
| TD Waterhouse Canada Inc. | 149 | $1.21K | 0.00% | +149 | New |
| AllSquare Wealth Management LLC | 185 | $1.00K | 0.00% | +185 | New |
| Plante Moran Financial Advisors, LLC | 2 | $0 | 0.00% | +2 | New |
| Forbes J M & Co LLP | 0 | $0 | 0.00% | −73,500−100.0% | Sold out |
| White Pine Investment CO | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |